Cost-effectiveness of treatment
DOI:
https://doi.org/10.47196/diab.v53i2Sup.240Keywords:
diabetes, treatmentAbstract
Available studies of the population-based costs of diabetes care generally refer to countries with the highest economic development. There are reliable data on the costs of diabetes in the United States (USA) that were calculated by the American Diabetes Association (ADA) in the years 2002, 2007, 2012 and 2017. As the methods used in These analyzes are similar, comparisons can be made with acceptable precision.
References
- Riddle MC, Herman WH. The cost of diabetes care. An elephant in the room. Diabetes Care 2018; 41:929-932.
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018; 41:917-928.
- Cuarta Encuesta Nacional de Factores de Riesgo. Dirección Nacional de Promoción de la Salud y Control de Enfermedades Crónicas No Transmisibles. Argentina 2018. Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000001444cnt-2019-04_4ta-encuesta-nacional-factores-riesgo.pdf.
- Gagliardino JJ, Olivera E, Etchegoyen GS, Guidi ML, Caporale JE, Martella A, de la Hera M, Siri F, Bonelli P. PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diab Res Clin Pract 2006; 9:284-291.
- Gagliardino JJ, Lapertosa S, Pfirter G, Villagra M, Caporale JE, González CD, Elgart J, González L, Cernadas C, Rucci E, Clark C Jr. The PRODIACOR. Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care. Diabet Med 2013; 30(9):1102-1111.
- Wan EYF, Fung CSC, Jiao FF, et al. Five-year effectiveness of the multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses a population based and propensity-matched cohort study. Diabetes Care 2018; 41:49-59.
- Jiao FF, Fung CSC, Wan EYF, et al. Five-year cost effectiveness of the multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM). Diabetes Care 2018; 41:250-257.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
